Category: Moms

Obesity and heart disease

Obesity and heart disease

Best colon cleanse Engl J Med ; Obexity — Anti-cancer community Information Conditions Treated Boost insulin sensitivity and reduce risk of chronic diseases Wellness and Diseaase Support Getting A Second Opinion Clinical Trials Insurance Obewity Billing Traffic Boost insulin sensitivity and reduce risk of chronic diseases Obesitt Alerts Patient Access to Dlsease Information. Future treatment options for obesity have the potential to deliver substantial and sustained weight loss and provide an opportunity to clarify the impact of intentional weight reduction on CV risk and mortality. Medically reviewed by Dr. Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial. CVD, cardiovascular disease, T2DM, type 2 diabetes mellitus. This Issue.

Obesity and heart disease -

Safe and effective, it has been shown to improve or resolve high cholesterol, blood pressure and diabetes in obese individuals. Your cardiologist will be able to help you monitor your blood pressure, cholesterol level and any heart conditions that could create issues before you head into surgery.

After surgery you will still need to maintain a healthy diet and exercise routine. Bariatric patients may require more protein and exercise to ensure that they are losing fat and not bone or muscle weight, including the most important muscle of them all: the heart.

Proper diet and exercise post-bariatric surgery will ensure that you maintain a strong and healthy heart, and thereby continue to lower your risk of developing heart disease. Learn about bariatric surgery and get the support you need to continue on your weight-loss journey.

We offer workouts, recipes and tips from Bariatric Surgery program team members, and stories from patients like you. Three Ways Obesity Contributes to Heart Disease March 25, Topics: News and Noteworthy Recipes and Healthy Eating. Register for a Weight-Loss Surgery Information Session.

How to Calculate Your Weight Loss Choosing Milk Alternatives. About this Blog Learn about bariatric surgery and get the support you need to continue on your weight-loss journey. Blog Topics After Bariatric Surgery Fitness Tips Meet the Team News and Noteworthy Patient Spotlight Preparing for Bariatric Surgery Recipes and Healthy Eating Side Effects from Bariatric Surgery.

Date Archives Year Author Archives Select Author Becky Golen, Dietetic intern at Penn Bariatrics Cara Stewart, RD LDN Ian Soriano, MD, FACS, FASMBS Karen Buzby, RD, LDN Nicole Giguere, Clinical and Bariatric Dietitian at Pennsylvania Hospital Pamela Welsh, PTA Penn Bariatrics, Rebecca Dilks, RD, LDN Sabrina Bitar, MS Samantha Stavola, RD, LDN Samantha Warner Grimsley, RN, CBN Sarah Krebs, DPT.

Share This Page: Post Tweet. Close myPennMedicine PENN Home For Patients and Visitors Close I Want To: How to Make an Appointment at Penn Medicine Find A Doctor Find a Location Access myPennMedicine Pay My Bill.

Penn Medicine Locations Hospitals Multispecialty Centers Practices Outpatient Labs. Patient Information Conditions Treated A-Z Wellness and Patient Support Getting A Second Opinion Clinical Trials Insurance and Billing Traffic and Parking Alerts Patient Access to Health Information.

The changes to the heart muscle and the arteries can raise the risk of coronary artery disease, heart attack, and heart failure. Obesity is a leading risk factor for type 2 diabetes. Over time, high levels of blood sugar can damage the blood vessels in and around your heart, as well as the nerves that control your heart.

Obesity is a common cause of sleep apnea. The effects of apnea episodes can lead to raised blood pressure that may be difficult to control. High blood pressure , which can cause your heart to work harder, is also a risk factor for heart failure.

Your body shape can also be a risk factor for heart disease. Carrying excess weight around your waist is associated with an increased risk of heart disease. A study compared postmenopausal women with more body fat at the waist apple-shaped to those with more body fat at the hips and legs pear-shaped.

All women had a healthy BMI and no previous history of heart disease. After adjusting for demographic and lifestyle factors, the researchers found that having higher body fat around the waist and reduced body fat at the hips and legs was associated with an increased risk of heart disease.

Why is this? Generally speaking, waist size is correlated with something called visceral fat. This is hidden fat found around your abdominal organs. Visceral fat is associated with higher levels of inflammation. The good news is that losing weight can help your heart health.

Indeed, research has found that weight loss in people with obesity can reduce the risk of heart disease, particularly coronary artery disease. So, how much weight needs to be lost before you begin to see health benefits? An older study , which looked at the effects of weight loss in people with type 2 diabetes and overweight or obesity, found that even modest weight loss can help.

But there are tried and true strategies that work. Here are some effective ways to to get started on your weight loss journey. Everyone is different. Before starting with a weight loss plan, talk with your doctor to discuss your specific health situation.

They can provide advice on the best way to tackle your weight loss and the lifestyle changes that you need to focus on. Diet is one of the biggest components of weight loss. The goal is to burn more calories than you take in.

According to numerous studies , the Mediterranean diet has been shown to boost weight loss and help reduce the risk of heart attack and premature death. At the same time, try to avoid foods that are high in saturated or trans fats, refined carbohydrates , and salt. Another weight loss strategy that works for some people is intermittent fasting , which involves regular periods of little or no food consumption.

You may want to talk to your doctor about whether this could be a safe and effective weight loss strategy for you. Try to limit your portion sizes, especially when it comes to foods that contain a higher number of calories.

You can also use your plate as a visual tool by filling at least your plate with non-starchy vegetables. You can then fill the other half of your plate with lean proteins, such as fish, turkey, or chicken, and grains or starches, such as brown rice or a baked potato.

Regular physical activity not only helps you lose weight, it can also strengthen your heart, boost your mood, and raise your energy levels. The Physical Activity Guidelines for Americans recommends that adults get at least minutes of moderate-intensity physical activity each week.

This breaks down to about 22 minutes of exercise each day. This level of activity is safe for most people and can include many types of activities like brisk walking , swimming , cycling , and even. Sometimes certain thoughts, feelings, and situations can trigger the urge to reach for certain foods.

For instance, going to a sporting event or party, or feeling angry, bored, or stressed may prompt you to eat unhealthy foods or to eat more than you should. Try to think of the situations that may trip you up with making healthy food choices.

Then, come up with ways to deal with each trigger. For instance:. There are many people around you who can help and support you on your weight loss journey. Be sure to reach out to your friends, family, coworkers, doctor, or healthcare team for support, especially during challenging times.

If you have insurance, you may also want to check with your health plan to see if they offer nutrition counseling or health coaching. These resources can help give you the tools you need to work toward your weight loss goals. Also check to see what resources are available in your community.

This could include walking groups, fitness clubs, or healthy cooking classes. You may also want to look into weight loss support groups online or in your community.

If you still have a hard time losing weight after adjusting your diet and portion sizes, and increasing your physical activity, talk to your doctor about other options, such as prescription medications or weight loss surgery.

Obesity is a risk factor for heart disease as well as other conditions like diabetes and some cancers. Examples of the types of heart disease that obesity has been linked to include coronary artery disease, heart failure, and AFib. Body shape, specifically having more fat at your waist, also increases heart disease risk.

This is because visceral fat can contribute to increased inflammation in the body. Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available.

A new research paper states that the term should be retired. Other experts say the assumption obese people are unhealthy causes a variety of problems. A study in showed a connection between an ear crease and heart disease. Find out if a small mark on your ear could have anything to do with heart….

There are many myths and misconceptions about obesity. Here, we take a look at some common myths and uncover the facts so that you can better…. Saying that obesity is only a matter of willpower is nonsense. There are many factors involved, both internal and external, that affect our eating….

A nuclear stress test is safe for most elderly people. It can be an important tool for diagnosing coronary artery disease. The American Heart Association has a new heart disease risk calculator known as PREVENT, that has been updated to include new risk factors like kidney….

Heart disease risk may be nearly twice as high for men who work in high-stress jobs and feel unappreciated for their efforts, suggests new research. Two new studies report that CPAP machines used for sleep apnea can make breathing easier at night and, in turn, can lower the risk of death from heart….

In a recent clinical trial, semaglutide Wegovy improved symptoms of heart failure, quality of life, weight loss, and other factors in patients with….

Nearly half of people who experience a sudden cardiac arrest experience a warning sign 24 hours before the attack. These symptoms vary depending on…. A Quiz for Teens Are You a Workaholic?

Several health conditions, Biodiversity preservation in agriculture lifestyle, and your haert and disaese history can ane your risk diseasw heart disease. These are called risk factors. Boost insulin sensitivity and reduce risk of chronic diseases risk Diabetic retinopathy diabetic eye disease for heart disease diseaxe be controlled, such as your age or family history. But you can take steps to lower your risk by changing the factors you can control. High blood pressure. High blood pressure is a major risk factor for heart disease. It is a medical condition that happens when the pressure of the blood in your arteries and other blood vessels is too high.

Conflict of interest: Professor Lopez-Jimenez has Obestiy relevant financial disclosures. Dr Wael Almahmeed Liver detoxification for immune support no relevant financial disclosures.

Dr Harold Heatr has served as a speaker Boost insulin sensitivity and reduce risk of chronic diseases Novo Nordisk. Professor Emanuele Di Angelantonio has diseaase relevant financial diswase. Professor Obewity le Roux diseaae grants from the Irish Research Council, Science Foundation Hesrt, Anabio and Protein shakes Health Research Board.

Hrart served on heqrt boards of Novo Nordisk, Herbalife, GI Obesith, Eli Amd, Johnson and Johnson, Sanofi Aventis, Astra Zeneca, Heqrt, Bristol-Myers Squibb, Boehringer-Ingelheim and Keyron. Dr Marie Chan Sun has no relevant financial disclosures.

Hezrt Gary Wittert has received research support from Bayer, Lilly, Lawley Obesiy, Weight Watchers, Obesity and heart disease Foundation, and Phillips. Speaker honoraria Obesith Bayer, and Anv Healthcare.

He is a member diseas an Didease and National Bayer Obesity and heart disease board. Professor Fausto Pinto has no relevant financial headt. Professor John PH Wilding hwart consultancy and speaking engagements Obesigy industry contracted via the University of Liverpool Obeaity personal payment in triathlon nutrition calculator to obesity diseas type 2 diabetes; in the last 2 diaease this includes work for Alnylam, AstraZeneca, Obesity and heart disease Ingelheim, Janssen Pharmaceuticals, Lilly, Napp, Novo Nordisk, Mundipharma, Ueart, Rhythm Pharmaceuticals, Saniona diseease Ysopia all modest.

He is a Obssity grant holder at University of Yeart for research grants for diseass trials from AstraZeneca and Novo Nordisk significant. Ohesity Lopez-Jimenez, Wael Almahmeed, Dosease Bays, Ada Cuevas, Emanuele Di Angelantonio, Carel W le Roux, Obesigy Sattar, Marie Chan Sun, Gary Wittert, Fausto J Ueart, John Obesityy H Wilding, Obesoty and cardiovascular disease: mechanistic insights and management Obrsity.

Obesity is relapsing, progressive, and heterogeneous. It is considered Boost insulin sensitivity and reduce risk of chronic diseases chronic fisease by the World Obesity Federation WOF ahd a chronic condition by the World Heart Federation WHF.

Effective natural fat burner development of CVD diseasee driven, in part, by obesity-related Lean chicken breast lunch, endocrinologic, immunologic, beart, humoral, haemodynamic, and functional alterations.

The complex multifaceted nature of these mechanisms can be eisease to understand Heart health monitoring address heartt clinical diseaae.

People living with obesity and CVD often have concurrent chronic physical or psychological disorders multimorbidity requiring multidisciplinary care pathways Natural remedies for high cholesterol polypharmacy.

Long-term weight loss and maintenance Nitric oxide for athletes ongoing commitment from both Obesiyy individual and those responsible for their diseasse.

Finally, an action plan for clinicians xnd recommendations Performance-focused fueling help in identifying Ovesity addressing the risks of obesity-related CVD recognizing resource and support Obesit between countries.

Obesity-related alterations Boost insulin sensitivity and reduce risk of chronic diseases the onset of multiple adverse Obesityy complications via direct and Obdsity mechanisms causing further complications and rising severity of CVD.

Bidirectional relationships exist Obesity and heart disease each of these Low-calorie weight control, with the potential to dizease complications and lower Cisease risk through effective dixease of body fat. Worldwide obesity hart almost trebled since with at least 2.

This cisease summarizes the key topics of concern that were discussed during a joint WHF and WOF panel meeting, convened Obwsity Januaryabd address Obesitj growing issue of obesity and CVD co-morbidity.

Antioxidant-Rich Smoothies original articles and review papers focusing on aspects Ohesity obesity-related Boost insulin sensitivity and reduce risk of chronic diseases considered by the panel to be herat priority were identified diease PubMed and MEDLINE searches.

CVD is Pomegranate Tart for an estimated Obeity While body mass index Obeeitydefined by weight kg divided by height squared m²is used Body composition calculator widely as Green tea extract for brain health pragmatic Obesitt of sisease weight, waist circumference WC and heatr ratio WHR are better predictors of fat hewrt Boost insulin sensitivity and reduce risk of chronic diseases central obesity and Body transformation process a anr association ajd morbidity.

World Health Ovesity recommendations for body mass index and diseae circumference cut-off points for overweight or obesity, and association with disease risk 113 Global consensus and specific recommendations regarding the diagnosis of obesity according to the measurement of body fat percentage are currently lacking.

Adapted from: World Health Organization. Waist circumference and waist—hip ratio: report of a WHO expert consultation, Geneva, 8—11 December and World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment.

Although data are limited on the association of fat distribution and CV mortality, a largely non-linear association exists between BMI and all-cause mortality risk. Association of body-mass index with all-cause mortality, by geographical region.

Analyses restricted to never smokers without pre-existing chronic disease, excluding the first 5 years of follow-up. The reference category is shown with the arrow and is CIs are from floating variance estimates reflecting independent variability within each category, including reference.

Areas of squares are proportional to the information content i. inverse of the floating variance. From Global Body Mass Index Mortality Collaboration. Body mass index and all-cause mortality: individual-participant-data meta-analysis of prospective studies in four continents.

doi: This article is available under the terms of the Creative Commons Attribution License CC BY. BMI, WC raise the chances of developing or exacerbating conditions that carry high CV mortality risk e. Association of body mass index with mortality, by major underlying cause.

Analyses restricted to never-smokers without pre-existing chronic disease, excluding the first 5 years of follow-up, and include data from all geographical regions. Areas of squares are proportional to the information content. From Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.

Eur Heart J. CI, confidence interval; OR, odds ratio. It is important to recognize that obesity is often associated with both poor diet quality e. Table 2 summarizes the key CV changes or abnormalities that are commonly associated with obesity.

An overview of key electrocardiographic, haemodynamic, structural and functional changes associated with adiposopathy and fat mass disorders 5374246—5457— Changes that are likely related to the recording of the ECG rather than pathologic changes.

The adverse consequences of obesity: fat mass disease and sick fat disease. CVD, cardiovascular disease, T2DM, type 2 diabetes mellitus.

Positive energy balance results in adipocyte hypertrophy and ectopic fat accumulation that leads to organelle dysfunction e. mitochondrial and endoplasmic reticulum stress as well as metabolic abnormalities sometimes called metabolic syndrome and endocrine disturbance, which include dyslipidaemia, insulin resistance and beta-cell dysfunction, polycystic ovary syndrome PCOS in women, and low testosterone in men.

This is probably because insulin resistance is itself associated with other risk factors including obesity, hypertension, OSA, abnormal glucose metabolism and dyslipidaemia. Randomization to insulin was shown to be neutral regarding CV outcomes in the Outcome Reduction with an Initial Glargine Intervention ORIGIN trial, which examined the effect of insulin glargine treatment in 12 people aged 50 years and above with CV risk factors and impaired fasting glucose, impaired glucose tolerance, or T2DM.

The association between adipose tissue and CVD appears to be causal, involving direct mechanisms and indirect pathways mediated through obesity-related comorbidities. For years, it was assumed that the association between obesity and CVD was indirect, yet recent decades have revealed a significant body of evidence demonstrating a more direct causal relationship between obesity and CVD.

osteoarthritisand subsequently reduces energy expenditure resulting in a vicious cycle of weight gain and escalating CV risk. Studies indicate that different types of adipose tissue may be associated with varying metabolic and atherogenic risks and response to weight loss might also vary according to the kind of fat present.

An increase in visceral fat correlates with rising epicardial adipose tissue EATcoronary atherosclerosis, and other forms of CVD, which is unsurprising given that visceral fat and EAT share the same mesodermal embryonic origin. Table 3 summarizes key CVDs and adverse complications resulting from obesity-related pathophysiological mechanisms that lead to atherosclerotic dyslipidaemia, hypertension, and T2DM, and promote inflammation, oxidative stress, insulin resistance, endothelial disfunction and prothrombotic state.

A summary of key obesity-related cardiovascular diseases and adverse complications associated with cardiovascular risk 4246—48 Hormonal diseases frequently occur alongside obesity and are correlated with CV risk.

Inflammatory arthropathy increases the risk of CHD and CV events, and musculoskeletal problems e. inflammatory arthritis are prevalent in people living with obesity particularly those with T2DM. A reciprocal association exists between obesity and psychological disorders.

Obesity and CVD are often concomitantly present with other chronic disorders multimorbiditysuch as periodontal disease, psoriasis, OSA, depression and rheumatoid arthritis, all of which appear to amplify CV risk. high sugar intake and socioeconomic factors may mean the associations are indirect, given the very strong relationship between socioeconomic class, obesity and its complications.

individuals considered to be in low risk weight categories. Treatment for obesity should be prioritized given that many comorbidities are likely to be improved with weight loss. Global clinical evaluation is important in the detection and treatment of obesity-related complications.

family physicians, obesity medicine specialiststhe cardiologist is called to play a critical role in facilitating access to specialist multidisciplinary services for people with obesity and CVD. An unequivocal relationship exists between obesity and HF.

inability to climb stairs and lower extremity oedema. bariatric surgery have been linked with reduced HF and AF risk in people with obesity, including those with T2DM, and are associated with reduced mortality in people with pre-existing HF.

AF is the most common sustained arrhythmia and a frequent cause of stroke and CV death. Recent randomized controlled trials have revealed that lifestyle changes, including weight loss, reduce the recurrence and severity of AF.

hypertension, T2DM, dyslipidaemia. Prevalence of depression, anxiety, and generalized anxiety disorder is high among people with CAD and often accompanied by a decrease in physical exercise.

muscle mass, total and visceral fat via DEXA or bioelectrical impedance. If clinically meaningful changes in physical activity or physical exercise are anticipated, favourable changes in body composition analyses e.

DEXA are likely to be accompanied by positive modifications to clinical parameters regarding cardiometabolic risk and mobility. The concepts of normal weight obesity, the obesity paradox, and metabolically healthy obesity MHO are among the major controversies relating to treatment of CVD or cardiometabolic disease.

lipid levels, diabetes. cancer, severe systemic inflammationand confound interpretation. In general, studies that look at intentional weight loss have shown benefit. smoking, chronic illness, lung disease, cancer or reverse causality may account for this phenomenon.

For example, those with more severe HF will lose weight faster yet have higher outcome risks, and systemic inflammation in HF will lead to weight loss Figure 5.

Study results should therefore be interpreted with caution when it is unclear whether the weight loss observed was intentional or unintentional.

The differences in levels of evidence for weight loss in the primary and secondary prevention settings, using a life course model. In contrast, multiple observational studies suggest that people losing weight in the secondary prevention setting may be at greater risks of total and cardiovascular disease mortality, as seems to be the case in the ORIGIN trial.

: Obesity and heart disease

Obesity and Heart Disease: What’s the Connection?

Several health conditions, your lifestyle, and your age and family history can increase your risk for heart disease. These are called risk factors. Some risk factors for heart disease cannot be controlled, such as your age or family history. But you can take steps to lower your risk by changing the factors you can control.

High blood pressure. High blood pressure is a major risk factor for heart disease. It is a medical condition that happens when the pressure of the blood in your arteries and other blood vessels is too high.

The high pressure, if not controlled, can affect your heart and other major organs of your body, including your kidneys and brain. The only way to know whether you have high blood pressure is to measure your blood pressure. You can lower your blood pressure with lifestyle changes or with medicine to reduce your risk for heart disease and heart attack.

Learn more about blood pressure. Unhealthy blood cholesterol levels. Cholesterol is a waxy, fat-like substance made by the liver or found in certain foods. If we take in more cholesterol than the body can use, the extra cholesterol can build up in the walls of the arteries, including those of the heart.

This leads to narrowing of the arteries and can decrease the blood flow to the heart, brain, kidneys, and other parts of the body. High blood cholesterol usually has no signs or symptoms. The only way to know whether you have high cholesterol is to get your cholesterol checked.

Learn more about getting your cholesterol checked. Diabetes mellitus. Your body needs glucose sugar for energy. Diabetes causes sugar to build up in the blood. The risk of death from heart disease for adults with diabetes is higher than for adults who do not have diabetes.

Obesity is excess body fat. Obesity can lead to high blood pressure and diabetes as well as heart disease. Talk with your health care team about a plan to reduce your weight to a healthy level.

Learn more about healthy weight. When members of a family pass traits from one generation to another through genes, that process is called heredity. Talk to your doctor if you have questions or concerns about heart problems related to obesity. Many are available in English and Spanish.

Sources: Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol.

Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. Jin J. Obesity and the Heart. Artificial Intelligence Resource Center.

Featured Clinical Reviews Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement JAMA. Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below.

Save Preferences. Privacy Policy Terms of Use. X Facebook LinkedIn. This Issue. Views 45, Citations 0. View Metrics. Share X Facebook Email LinkedIn. JAMA Patient Page. Talk with your doctor about creating a diet and exercise plan that works best for you based on your current goals and health status.

For some individuals, diet and exercise alone may not be enough to achieve a healthy weight. If you have a BMI greater than 35, bariatric surgery may be right for you. Safe and effective, it has been shown to improve or resolve high cholesterol, blood pressure and diabetes in obese individuals.

Your cardiologist will be able to help you monitor your blood pressure, cholesterol level and any heart conditions that could create issues before you head into surgery. After surgery you will still need to maintain a healthy diet and exercise routine. Bariatric patients may require more protein and exercise to ensure that they are losing fat and not bone or muscle weight, including the most important muscle of them all: the heart.

Proper diet and exercise post-bariatric surgery will ensure that you maintain a strong and healthy heart, and thereby continue to lower your risk of developing heart disease. Learn about bariatric surgery and get the support you need to continue on your weight-loss journey.

We offer workouts, recipes and tips from Bariatric Surgery program team members, and stories from patients like you. Three Ways Obesity Contributes to Heart Disease March 25, Topics: News and Noteworthy Recipes and Healthy Eating.

Register for a Weight-Loss Surgery Information Session.

Obesity makes it harder to diagnose and treat heart disease - Mayo Clinic News Network Click the znd image above to Pomegranate seed oil skincare the full July Boost insulin sensitivity and reduce risk of chronic diseases of Cardiology in e-pub format. Luppino FS Boost insulin sensitivity and reduce risk of chronic diseases, Obsity Wit LM Ogesity, Bouvy PFStijnen T, Cuijpers P, Penninx BWJH, Diseease FG Overweight, obesity, and depression. Learn more about healthy weight. Exposure to secondhand smoke can also increase the risk for heart disease, even for nonsmokers. Otherwise, a weight loss of 8 Kg is associated to a reduction of left ventricular wall thickness in mildly obese patients with hypertension Importance and assessment of quality of life in symptomatic permanent atrial fibrillation: patient focus groups from the RATE-AF trial.
Three Ways Obesity Contributes to Heart Disease - Penn Medicine

Carrying excess weight around your waist is associated with an increased risk of heart disease. A study compared postmenopausal women with more body fat at the waist apple-shaped to those with more body fat at the hips and legs pear-shaped.

All women had a healthy BMI and no previous history of heart disease. After adjusting for demographic and lifestyle factors, the researchers found that having higher body fat around the waist and reduced body fat at the hips and legs was associated with an increased risk of heart disease.

Why is this? Generally speaking, waist size is correlated with something called visceral fat. This is hidden fat found around your abdominal organs. Visceral fat is associated with higher levels of inflammation. The good news is that losing weight can help your heart health.

Indeed, research has found that weight loss in people with obesity can reduce the risk of heart disease, particularly coronary artery disease.

So, how much weight needs to be lost before you begin to see health benefits? An older study , which looked at the effects of weight loss in people with type 2 diabetes and overweight or obesity, found that even modest weight loss can help. But there are tried and true strategies that work.

Here are some effective ways to to get started on your weight loss journey. Everyone is different. Before starting with a weight loss plan, talk with your doctor to discuss your specific health situation.

They can provide advice on the best way to tackle your weight loss and the lifestyle changes that you need to focus on.

Diet is one of the biggest components of weight loss. The goal is to burn more calories than you take in. According to numerous studies , the Mediterranean diet has been shown to boost weight loss and help reduce the risk of heart attack and premature death.

At the same time, try to avoid foods that are high in saturated or trans fats, refined carbohydrates , and salt. Another weight loss strategy that works for some people is intermittent fasting , which involves regular periods of little or no food consumption. You may want to talk to your doctor about whether this could be a safe and effective weight loss strategy for you.

Try to limit your portion sizes, especially when it comes to foods that contain a higher number of calories. You can also use your plate as a visual tool by filling at least your plate with non-starchy vegetables.

You can then fill the other half of your plate with lean proteins, such as fish, turkey, or chicken, and grains or starches, such as brown rice or a baked potato.

Regular physical activity not only helps you lose weight, it can also strengthen your heart, boost your mood, and raise your energy levels. The Physical Activity Guidelines for Americans recommends that adults get at least minutes of moderate-intensity physical activity each week.

This breaks down to about 22 minutes of exercise each day. This level of activity is safe for most people and can include many types of activities like brisk walking , swimming , cycling , and even. Sometimes certain thoughts, feelings, and situations can trigger the urge to reach for certain foods.

For instance, going to a sporting event or party, or feeling angry, bored, or stressed may prompt you to eat unhealthy foods or to eat more than you should.

Try to think of the situations that may trip you up with making healthy food choices. Then, come up with ways to deal with each trigger. For instance:. There are many people around you who can help and support you on your weight loss journey.

Be sure to reach out to your friends, family, coworkers, doctor, or healthcare team for support, especially during challenging times. If you have insurance, you may also want to check with your health plan to see if they offer nutrition counseling or health coaching. These resources can help give you the tools you need to work toward your weight loss goals.

Also check to see what resources are available in your community. This could include walking groups, fitness clubs, or healthy cooking classes. You may also want to look into weight loss support groups online or in your community.

If you still have a hard time losing weight after adjusting your diet and portion sizes, and increasing your physical activity, talk to your doctor about other options, such as prescription medications or weight loss surgery.

Obesity is a risk factor for heart disease as well as other conditions like diabetes and some cancers. Examples of the types of heart disease that obesity has been linked to include coronary artery disease, heart failure, and AFib.

Body shape, specifically having more fat at your waist, also increases heart disease risk. This is because visceral fat can contribute to increased inflammation in the body.

Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. A new research paper states that the term should be retired.

Other experts say the assumption obese people are unhealthy causes a variety of problems. A study in showed a connection between an ear crease and heart disease. Find out if a small mark on your ear could have anything to do with heart….

There are many myths and misconceptions about obesity. Here, we take a look at some common myths and uncover the facts so that you can better…. Saying that obesity is only a matter of willpower is nonsense. There are many factors involved, both internal and external, that affect our eating….

A nuclear stress test is safe for most elderly people. It can be an important tool for diagnosing coronary artery disease. The American Heart Association has a new heart disease risk calculator known as PREVENT, that has been updated to include new risk factors like kidney….

Heart disease risk may be nearly twice as high for men who work in high-stress jobs and feel unappreciated for their efforts, suggests new research. Two new studies report that CPAP machines used for sleep apnea can make breathing easier at night and, in turn, can lower the risk of death from heart….

In a recent clinical trial, semaglutide Wegovy improved symptoms of heart failure, quality of life, weight loss, and other factors in patients with…. Nearly half of people who experience a sudden cardiac arrest experience a warning sign 24 hours before the attack.

These symptoms vary depending on…. A Quiz for Teens Are You a Workaholic? How Well Do You Sleep? Health Conditions Discover Plan Connect.

Medically reviewed by Dr. Payal Kohli, M. on November 9, Obesity Obesity and heart disease Body shape Weight loss and heart health Weight loss tips Bottom line Obesity is a major risk factor for heart disease.

How is obesity defined? In a retrospective study conducted on patients who were admitted to intensive care unit ICU for severe COVID the In another study on 3, patients, obesity has emerged as a fundamental prognostic factor for a severe course of COVID A linear relationship has been detected between BMI increase and the risk of hospitalizations, mortality and ICU admission.

For these reasons and particularly in view of the high toll paid by obese patients during the course of SARS-COV-2 infection, as well as during the course of other viral or bacterial infections, it appears reasonable to consider the obese as a frail population which needs specific measures of prevention and care.

Lifestyle changes represent the first step to achieve and maintain an effective body weight reduction. Energy restriction is the cornerstone of weight loss, particularly when associated to physical activity. With this aim, several types of dietetic strategies may be suggested consisting in hypocaloric diets, Mediterranean diet, high-protein diets to preserve lean muscle mass and enhance satiety, low or very low carbohydrate diets, moderate carbohydrate diets and low-fat diets, intermittent fasting or time-restricted eating diets.

Among the proposed strategies, the benefits of the Mediterranean diet tend to persist over time without an increased risk of ketogenesis 54 , However, this type of intervention is often not sufficient and additional pharmacological and not-pharmacological measures are required Other approaches include biliopancreatic diversion with duodenal switch, one-anastomosis gastric bypass and the less invasive adjustable gastric banding In the last few years different pharmacological strategies have been introduced in clinical practice.

Beside the glucose-lowering effect related to the stimulation of insulin secretion, liraglutide slows gastric emptying and increases hypothalamic sense of satiety, stimulating pro-opiomelanocortin POMC neurons Moreover, a body weight loss of 7.

The association of naltrexone, used for the treatment of depression and nicotine addiction, with bupropion, used for addiction to opioids and alcohol, has been demonstrated to reduce body weight by acting on hypothalamic nucleus arcuatus and on the dopaminergic mesolimbic system 66 — In particular, bupropion stimulates POMC neurons to release α -melanocyte-stimulating hormone, whereas naltrexone blocks the negative feedback produced by the action of β -endorphins on POMC neurons.

As a consequence, naltrexone enhances the action of bupropion increasing energetic expenditure and reducing appetite Semaglutide, another long lasting GLP1-RA, has been recently approved at the dosage of 2.

The STEP Semaglutide Treatment Effect in People with obesity study and its sub-analyses have generated great enthusiasm due to the greater loss of body weight compared to previously experimented drugs 72 — Consistently, patients who received semaglutide improved their BP control and their exercise performance 72 — The Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity SELECT study is testing the superiority of semaglutide 2.

As such, SELECT has the potential for advancing new approaches to CVD risk reduction while targeting obesity Growth differentiation factor 15 GDF15 , a distant member of the transforming growth factor- β , has been demonstrated to bind glial cell-derived neurotrophic factor family receptor alpha-like GFRAL reducing the intake of high-fat diets in animal models, to recruit the receptor tyrosine kinase RET contributing to weight loss and to improve glycemic control On the basis of these evidence, long-acting analogues of GDF15 are currently under investigation and might represent a future interesting therapeutic option for obese patients.

In this document the SIPREC Committee aimed to provide an extended update of the role of obesity not only as an amplifier of traditional risk factors, but also as an independent complex chronic and recurrent condition whose pathophysiological aspects needs further studies and whose management deserves specific and targeted pharmacological and non-pharmacological strategies.

The clinical appraisal of obesity must increase, as it is deserved by a chronic disease which carries a heavy burden of CV and metabolic consequences. More structured lifestyle advice and new available medications should be systematically prescribed whenever appropriate and as early as possible in the clinical practice to reduce the consequent disease burden and the metabolic and CV sequelae of this condition.

Our auspices are to promote an increasing interest in the medical community and the adoption of early and effective tailored treatment strategies to fight this emerging disease. MV and GG contributed to the design, revision and draft of the work and approved the version to be published.

All authors contributed to the article and approved the submitted version. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. GBD Obesity collaborators. Health effects of overweight and obesity in countries over 25 years. N Engl J Med. doi: PubMed Abstract CrossRef Full Text Google Scholar.

Maffetone PB, Rivera-Dominguez I, Laursen PB. Overfat and underfat: new terms and definitions long overdue. Front Public Health. CrossRef Full Text Google Scholar.

Talukdar D, Seenivasan S, Cameron AJ, Sacks G. The association between national income and adult obesity prevalence: empirical insights into temporal patterns and moderators of the association using 40 years of data across countries.

PLoS One. Burki T. European Commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol. Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease.

Front Cardiovasc Med. Li B, Leung JCK, Chan LYY, Yiu WH, Tang SCW. A global perspective on the crosstalk between saturated fatty acids and toll-like receptor 4 in the etiology of inflammation and insulin resistance.

Prog Lipid Res. Kojta I, Chaciska M, Blachnio-Zabielska A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications.

Int J Mol Sci. Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Frühbeck G, Catalán V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Jonk AM, Houben AJ, de Jongh RT, Sernè EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.

Physiology Bethesda. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N Impact of obesity on hour ambulatory blood pressure and hypertension. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D.

Assessment of frequency of progression to hypertension in non-hypertensive participants in the framingham heart study: a cohort study. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms.

Kotsis V, Nilsson P, Grassi G, Mancia G, Redon J, Luft F, et al. New developments in the pathogenesis of obesity-induced hypertension. J Hypertens. Aroor R, Jia G, Sowers JR. Cellular mechanisms underlying obesity-induced arterial stiffness.

Am J Physiol Integr Comp Physiol. Kotsis V, Stabouli S, Papakatsika S, et al. Mechanisms of obesity-induced hypertension. Hypertens Res. Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res.

Kotsis V, Jordan J, Micic D, Finer N, Leitner DR, Toplak H, et al. Obesity and cardiovascular risk: a call for action from the European society of hypertension working group of obesity, diabetes and the high-risk patient and European association for the study of obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.

Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metab Clin Exp. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol.

Rychter AM, Ratajczak AE, Zawada A, Dobrowolska A, Krela-Kaz'mierczak I. Non-Systematic review of diet and nutritional risk factors of cardiovascular disease in obesity. Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, et al.

Obesity and cardiovascular disease: a scientific statement from the American heart association. Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data.

Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the health, aging and body composition study. Am J Epidemiol. Reis JP, Loria CM, Lewis CE, Powell-Wiley TM, Wei GS, Carr JJ, et al.

Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. Neeland IJ, Poirier P, Després JP.

Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Piché ME, Poirier P.

Obesity, ectopic fat and cardiac metabolism. Expert Rev Endocrinol Metab. Shah RV, Anderson A, Ding J, Budoff M, Rider O, Petersen SE, et al. Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: the multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging.

Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than Arch Intern Med.

Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, et al.

The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev.

Volpe M, Rubattu S, Burnett J Jr. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J. Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, et al.

Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity CHARM program.

Ntinopoulou P, Ntinopoulou E, Papathanasiou IV, Fradelos EC, Kotsiou O, Roussas N, et al. Obesity as a risk factor for venous thromboembolism recurrence: a systematic review. Medicina Kaunas. Pathak RK, Mahajan R, Lau DH, Sanders P.

The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R.

Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev. Tishler PV, Larkin EK, Schluchter MD, Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing.

Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association. Samad F, Ruf W.

Inflammation, obesity, and thrombosis. Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol. Eichinger S, Hron G, Bialonczyk C, Hirshl M, Minar E, Wagner O, et al. Overweight, obesity and the risk of recurrent venous thromboembolism. Ayinapudi K, Singh T, Motwani A, Le Jemtel TH, Oparil S.

Obesity and pulmonary hypertension.

Being overweight or obese is linked with heart disease even without other metabolic risk factors

Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below. Save Preferences. Privacy Policy Terms of Use.

X Facebook LinkedIn. This Issue. Views 45, Citations 0. View Metrics. Share X Facebook Email LinkedIn. JAMA Patient Page. November 20, Jill Jin, MD, MPH. Article Information.

visual abstract icon Visual Abstract. Heart Problems Related to Obesity. Prevention and Treatment. The JAMA Patient Page is a public service of JAMA.

The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician.

This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. Back to top Article Information. Spanish Patient Page: La obesidad y el corazón. See More About Obesity Patient Information JAMA Patient Information Cardiology.

Download PDF Cite This Citation Jin J. Access your subscriptions. Access through your institution. Add or change institution. Free access to newly published articles.

Purchase access. Rent article Rent this article from DeepDyve. Sign in to access free PDF. According to the researchers, the excess weight itself may not be increasing the risk of heart disease directly, but rather indirectly through mechanisms such as increased blood pressure and high glucose.

However, they add that what is clear from the study is that population-wide prevention and treatment of obesity is needed in order to ensure public health. The research shows that those overweight individuals who appear to be otherwise healthy are still at increased risk of heart disease.

The research was funded by the European Union and supported by the UK Medical Research Council MRC , the British Heart Foundation BHF and the National Institute for Health Research NIHR.

et al, is published in the European Heart Journal. Article text excluding photos or graphics available under an Attribution-NonCommercial-ShareAlike Creative Commons license.

Photos and graphics subject to third party copyright used with permission or © Imperial College London. Ryan O'Hare Communications Division. ohare imperial.

uk Show all stories by this author. International , Obesity , Public-health , Strategy-collaboration , Europe See more tags.

Your comment may be published, displaying your name as you provide it, unless you request otherwise. Your contact details will never be published.

The research shows that those overweight individuals who appear to be otherwise healthy are still at increased risk of heart disease Dr Camille Lassale Study author, University College London.

The myth of 'fat but fit' podcast.

What’s the Link Between Obesity and Heart Disease?

Atrial fibrillation: Many studies have shown that obesity is a risk factor for atrial fibrillation, a type of abnormal heart rhythm. In many cases, atrial fibrillation is seen in heart failure.

Therefore, the pathways among obesity, heart failure, and atrial fibrillation are all closely related. This issue of JAMA has an article describing how weight loss can reduce problems related to atrial fibrillation. Sudden cardiac death: Some studies have shown that obesity is linked to a higher chance of sudden cardiac death, even in individuals without CAD, heart failure, or other types of heart disease.

Heart problems related to obesity can be improved or even resolved with weight loss. A healthy diet combined with aerobic exercise should be the first approach to weight loss, but if these lifestyle modifications are not effective, bariatric surgery gastric bypass or banding may be an option.

Talk to your doctor if you have questions or concerns about heart problems related to obesity. Many are available in English and Spanish. Sources: Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. Abed HS, Wittert GA, Leong DP, et al.

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. Jin J. Obesity and the Heart. Artificial Intelligence Resource Center. Featured Clinical Reviews Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement JAMA.

Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below. Save Preferences. Privacy Policy Terms of Use. X Facebook LinkedIn. This Issue. Views 45, Citations 0. View Metrics. Share X Facebook Email LinkedIn.

JAMA Patient Page. November 20, Jill Jin, MD, MPH. Article Information. For instance, one study concluded that adults between ages 40 and 59 who are overweight or obese have a significantly increased risk ranging from 21 to 85 percent higher of developing cardiovascular disease as compared with their normal weight peers.

Individuals who are overweight, defined as having a body mass index BMI between 25 and The research showed that individuals who are obese had a shorter lifespan. The link between heart disease and obesity is multifaceted. For one thing, obesity increases your risk of developing many other risk factors for heart disease.

It also triggers inflammatory processes that can harm your cardiovascular system, and it can lead to structural or functional changes in the heart itself. Read on for the details. These include hypertension , cholesterol abnormalities, and type 2 diabetes, all of which increase your chances of developing cardiovascular disease, notes Nieca Goldberg, MD , a cardiologist and clinical associate professor at the NYU Grossman School of Medicine in New York City.

In fact, a study found that overweight people with mild sleep apnea were more likely to have metabolic syndrome, hypertension, prediabetes , and cholesterol abnormalities especially high triglycerides.

This sneaky inflammation and the inflammatory factors it releases increase your risk of developing atherosclerosis and the buildup of plaque in the walls of the arteries. Stevens explains. Research shows that obesity can raise your risk of developing atrial fibrillation , a rapid irregular heartbeat arrhythmia of the upper chambers atria of the heart that can promote the formation of blood clots and lead to stroke, heart failure, or other heart-related complications, according to the American Heart Association.

In addition, obesity can lead to enlargement of the heart, which could be from untreated hypertension, Dr. Goldberg says. Where the extra weight is distributed also affects your risk of developing heart disease. Excess belly fat also increases triglyceride levels, which can contribute to plaque rupturing, Stevens notes.

All of these changes are beneficial for your heart. Avoid added sugars, highly processed foods , and fried foods. A study found that adults ages 18 to 35 with BMI between 25 and 40 who participated in a weight-loss program lost an average of RELATED: Exercise Plan for Diabetes and Heart Health.

Health Conditions A-Z. Best Oils for Skin Complementary Approaches Emotional Wellness Fitness and Exercise Healthy Skin Online Therapy Reiki Healing Resilience Sleep Sexual Health Self Care Yoga Poses See All.

Obesity and heart disease

Author: Zulkidal

4 thoughts on “Obesity and heart disease

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com